Browse by author
Lookup NU author(s): Dr Heather Dickinson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Epithelial ovarian cancer kills about 1700 in the UK each year. Ten to fifteen percent of all cases are diagnosed early when there is still a good chance of cure. The treatment of early stage disease involves surgery to remove disease often followed by chemotherapy. The largest clinical trials of this adjuvant therapy show an overall survival (OS) advantage with adjuvant platinum based chemotherapy but the precise role of this treatment in sub-groups of patients with differing prognoses needs to be defined.
Author(s): Winter-Roach BA, Kitchener HC, Dickinson HO
Publication type: Review
Publication status: Published
Journal: Cochrane Database of Systematic Reviews
Year: 2009
Issue: 1
Pages: CD004706
ISSN (electronic): 1469-493X
Publisher: Update Software Ltd.
URL: http://dx.doi.org/10.1002/14651858.CD004706.pub2
DOI: 10.1002/14651858.CD004706.pub2
Notes: Updated version of review published 2012: Winter-Roach BA, Kitchener HC, Lawrie TA. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD004706. DOI: 10.1002/14651858.CD004706.pub4.
